Investigated for use/treatment in breast cancer, cancer/tumors (unspecified), HIV infection, hepatitis (viral, C), and solid tumors.

Investigated for use/treatment in addictions.

Investigated for use/treatment in cancer/tumors (unspecified).

Investigated for use/treatment in malaria.

Investigated for use/treatment in inflammatory disorders (unspecified).

Investigated for use/treatment in cancer/tumors (unspecified).

Investigated for use/treatment in thrombocytopenia.

Intended for the treatment of Diabetes Mellitus Type 1 and 2.

For the treatment of chronic and breakthrough pain in advanced cancer patients as well as for the treatment of opioid dependence.

Investigated for use/treatment in immunodeficiency and infectious and parasitic disease (unspecified).

Investigated for use/treatment in hepatitis (viral, B).

Indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns.

For the control of absence (petit mal) seizures that are refractory to other drugs.

B-cell non-Hodgkin's lymphoma

Chronic angina and Coronary Artery Disease

Plasmin assists with the healing of minor burns, superficial wounds, ulcers, surgical wounds, and superficial hematomas

Investigated for use/treatment in pain (acute or chronic).

Investigated for use/treatment in hepatitis (viral, C), leukemia (lymphoid), leukemia (myeloid), leukemia (unspecified), and melanoma.

For reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis.